Novo Nordisk recalls faulty cartridge holders in insulin pens was announced 5 July 2017. 

iating a recall of insulin cartridge holders used in some NovoPen Echo insulin pen devices distributed in the United States because the holders may crack or break if exposed to certain chemicals, including certain cleaning agents. Using a device with a cracked or broken cartridge holder could result in delivery of a smaller dose of insulin than expected, the company said. Separately, Novo Nordisk warned of a similar problem with NovoPen Echo and NovoPen 5 devices distributed in Canada.

Read more: Novo Nordisk Recalls Cartridge Holders In Certain Novopen Echo® Insulin Delivery Devices

 

Nasal Glucagon Fixes Severe Hypoglycemia in Type 1 Diabetes, as reported at the ADA 2017 Scientific Sessions in June, 2017 by researchers at the University of Minnesota School of Medicine.

Giving one puff of a dry glucagon powder inside the nose of an adult with type 1 diabetes who was having a moderate to severe hypoglycemic episode was easy for a caregiver to do and led to recovery within 30 minutes in almost all patients in a phase 3 study. The treated patients recovered from hypoglycemia within a half hour in 96% of cases, and 90% of the caregivers (typically a spouse) found the product easy to use, Elizabeth R Seaquist, MD, University of Minnesota School of Medicine, Minneapolis.

Read more: Nasal Glucagon Fixes Severe Hypoglycemia in Type 1 Diabetes

 

‘Smart’ insulin patches developed at UNC, NCSU one step closer to market, as published in The News & Observer, 30 June 2017.

Zhen Gu, whose team at the UNC-N.C. State Biomedical Engineering Program has been leading the effort to develop “smart” insulin patches for treating diabetes, co-founded a company based in Research Triangle Park two years ago with the idea of delivering his patented diabetes treatment to people around the world. Now his company, Zenomics Inc., has received a $5.8 million investment from Chinese company MicroPort Scientific to help fulfill that goal.

Their solution is a glucose-responsive “smart” insulin patch that is worn on the skin and instantaneously releases insulin as needed. Roughly the same size as a dime, the patch contains 121 microneedles, each thinner than a human hair and pre-loaded with tiny packets of insulin and glucose oxidase, an enzyme that immediately responds to high glucose levels and sparks a reaction that releases insulin.

 

Read more: ‘Smart’ insulin patches developed at UNC, NCSU one step closer to market

 

Temperature-reading ‘smartmat’ catches diabetic foot ulcers early, as reported by BusinessWire, 29 June, 2017 and published in the July 2017 issue of Diabetes Care.

Podimetrics, Inc., a medtech and services company focused on the early detection and prevention of diabetic foot ulcers (DFU), announced results of a landmark study that demonstrated that the Podimetrics SmartMat™ detected as many as 97% of developing nontraumatic plantar foot ulcers on average five weeks before they presented clinically. Importantly, 86% of patients used the mat at least three times per week and 88% of respondents reported it being easy-to-use, suggesting that patients readily accept this practical, new monitoring technology.

Read more: Podimetrics Publishes Landmark Study Demonstrating 97% Sensitivity in Predicting Emergence of Diabetic Foot Ulcers Five Weeks Prior to Clinical Presentation

 

 

Share This